Earendil: A Blueprint for a Multipolar Life Sciences Era
The $787M financing points to a new global architecture in biotech
False
Advertisement
Related Content
Cell & Gene
Development & Clinical
Interviews
Musings from The Power List: Michael May
September 22, 2026
5 min read
CCRM CEO Michael May on quantum computing, commercialization, and the next era of cell therapy
Development & Clinical
Cell & Gene
Research News
Long-Term Data Boost MCO-010
September 21, 2026
2 min read
Four-year RESTORE results will shed new light on the durability of Nanoscope’s mutation-agnostic optogenetic therapy
Outsourcing
Supply Chain
Interviews
The Barriers Limiting Radiopharmaceutical Access
September 21, 2026
5 min read
From isotope supply to reimbursement, the practical challenges shaping real-world delivery in oncology
Small Molecules
Development & Clinical
Interviews
Musings from The Power List: Dajun Yang
September 15, 2026
4 min read
The Ascentage Pharma CEO on why next-generation small molecules are expanding into territory once reserved for biologics